Myopia
Conditions
Interventions
Test group 1:Wearing myopia frame glasses (optical monofocal lenses)+BBL myopia and amblyopia comprehensive treatment instrument red light feeding treatment+BBL myopia and amblyopia treatment instrume
Test group 2:Wearing myopia frame glasses (optical monofocal lenses)+BBL myopia and amblyopia comprehensive treatment instrument red light feeding treatment
Control group:Wearing myopia frame glasses (optical monofocal lenses)
Sponsors
The First Affiliated Hospital with Nanjing Medical University
Eligibility
Sex/Gender
All
Age
8 Years to 15 Years
Inclusion criteria
Inclusion criteria: (1)Age 8~15 years old, gender is not limited; (2)The patient was diagnosed as nearsighted according to the Guidelines for Prevention and Treatment of Myopia issued by the General Office of the National Health Commission (Medical Letter [2018] No. 393); (3)Optometry after cycloplegia -6.00D<equivalent spherical lens=-0.75D; (4)Anisometropia <1.5D, and astigmatism =2.5D; (5)The best corrected visual acuity in both eyes = 1.0; (6)Willing to wear uniformly issued frame glasses; (7)Able to actively cooperate with training and review regularly; (8)Understand the purpose of this experiment and participate voluntarily, and the person or guardian signs the informed consent.
Exclusion criteria
Exclusion criteria: (1)There are organic lesions affecting visual function in both eyes. (2)photosensitivity; or photophobia. (3)combined strabismus. (4)congenital color vision disorder. (5)Eye surgery (including strabismus surgery) within the past six months. (6)Have worn bifocals, progressive glasses, orthokeratology lenses, bifocal contact lenses, or other functional lenses within 3 months. (7)Previous or current use of atropine eye drops for myopia control. (8)Combined with ocular, systemic or other diseases that may be related to pathological myopia or affect refractive development, such as Marfan syndrome, retinopathy of prematurity, diabetes. (9)Patients who are taking drugs that may affect pupil size, accommodation, or have effects on the ocular surface (eg, atropine, antiallergic drugs). (10)Those who are participating in other clinical trials. (11)Others may increase the risks associated with participating in the research or using experimental products, or may affect the interpretation of the research results, and the researchers judge that they are not suitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Axial Length (AL); | — |
Secondary
| Measure | Time frame |
|---|---|
| Best Corrected Visual Acuity ;Spherical Equivalent; | — |
Countries
China
Contacts
Public ContactLiu Hu
The First Affiliated Hospital with Nanjing Medical University
Outcome results
None listed